RISK

Emerging Markets Report: The Power of the Patent

Retrieved on: 
Tuesday, May 10, 2022
EMC, Communication, RISK, NOT, US, LLC, Company, Securities Act of 1933, SHARE, Time, PAID, RESEARCH, Closed-end fund, Advertising, Editorial, Marketing, Awareness, Risk, Security (finance)

ORLANDO, Fla., May 10, 2022 (GLOBE NEWSWIRE) -- A report last month that the United States Patent and Trademark Office (the “USPTO”) has issued a patent related to ATMOFIZER TECHNOLOGIES INC.’S (CSE: ATMO; OTCQB: ATMFF) air and water purification technology is a significant milestone for the Company. Specifically, the issued patent, titled, “Ultra-Fine Particle Aggregation, Neutralization and Filtration” (US Patent Application No. 17/471,610) provides broad protection for the application of the Company’s air and water purification technology in the United States.

Key Points: 
  • cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration.
  • This communication is a paid advertisement and is not a recommendation to buy or sell securities.
  • Emerging Markets Consulting, LLC, and their owners, managers, employees, and assigns (collectively EMC) has been paid by the profiled company or a third party to disseminate this communication.
  • This compensation is a major conflict with our ability to be unbiased, more specifically:
    This communication is for entertainment purposes only.

MIMEDX Comments on Prescience Point’s False and Misleading Statements

Retrieved on: 
Monday, May 9, 2022
M&A, Culture, Board of directors, GBL, Arthur Andersen, Solution, Stanford University, Cancer Prevention and Research Institute of Texas, IQVIA, Annual general meeting, Risk, Chairperson, THC, RISK, NASDAQ, Control, Company, NYSE, Research institute, Investment, Novin, Industry, Pressure, Owens & Minor, Intention, Statement, ALL, Telephone, GHB, Gamma-Hydroxybutyric acid, LLP, Sale, Goal, Motivation, Growth, Ownership, Internet, Cancer prevention, Board, COVID-19, OMI, GLOBE, Review, Shareholder, Tenet Healthcare, Ethics, History, Science, AUM, Security (finance), Management, Risk management, Theranos, Medicine

MARIETTA, Ga., May 09, 2022 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today commented on Prescience Point Capital Management’s (“Prescience Point”) highly misleading press release on May 6, 2022. MIMEDX urges shareholders to vote “FOR” the Company’s highly qualified and independent directors – Dr. Phyllis Gardner and James L. Bierman – on the WHITE proxy card.

Key Points: 
  • A companys integrity and credibility stem from exemplary leadership, and MIMEDX does not compromise on its core values and commitments.
  • Both are highly respected in the life sciences industry and have made significant contributions to our successful turnaround, positioning MIMEDX for substantial shareholder value creation.
  • Mr. Asbahis commentary only reinforces the Boards belief that Prescience Points interests are short-term and not aligned with those of all shareholders.
  • While Prescience Point attempts to distract shareholders with misleading facts and statements, their public comments betray their true motivation Mr. Asbahi and Prescience Point explicitly stated their interest in a sale of AMNIOFIX or the entire business later this year.

Abercrombie & Fitch Co. to Report First Quarter 2022 Results on May 24, 2022

Retrieved on: 
Friday, May 6, 2022
COVID-19, Private Securities Litigation Reform Act, Dixie, RISK, Woman, Generation Z, Charli, ANF, Company, NYSE, Individual, Skin, Abercrombie & Fitch, Abercrombie & Fitch Co. v. Hunting World, Inc., Life, Abercrombie, Man, Social media, Fashion

Words such as estimate, project, plan, believe, expect, anticipate, intend, and similar expressions may identify forward-looking statements.

Key Points: 
  • Words such as estimate, project, plan, believe, expect, anticipate, intend, and similar expressions may identify forward-looking statements.
  • Except as may be required by applicable law, we assume no obligation to publicly update or revise our forward-looking statements.
  • About Abercrombie & Fitch Co.
    Abercrombie & Fitch Co. (NYSE: ANF) is a leading, global, omnichannel specialty retailer of apparel and accessories for men, women and kids through five renowned brands.
  • The iconic Abercrombie & Fitch brand was born in 1892 and aims to make every day feel as exceptional as the start of a long weekend.

Orgenesis Led Consortium Awarded €4M European Innovation Council Pathfinder Grant

Retrieved on: 
Tuesday, May 3, 2022
COVID-19, U.S. Securities and Exchange Commission, An Act to exempt a particular class of securities from the Securities and Exchange Act, Leiden University, Regenerative medicine, RISK, NASDAQ, GLOBE, Fausto Pocar, Securities Act of 1933, Hematopoietic stem cell transplantation, Patient, Protest and strikes of the CGT union 2021, Security (finance), Degenerative disease, JV, MIDA, Program, Cancer, GMP, Annual report, Energy Independence and Security Act of 2007, Diabetes, Artificial intelligence, Hospital, Tissue, Database, Potency (pharmacology), CGT, Medtech, Machine learning, CEO, Therapy, Technology, Research, AI, European Innovation Council, Cell, Risk, Pharmaceutical industry, Vaccine, EU, Labs

The grant is aimed at the development of technologies enabling production of autologous induced pluripotent stem cells (iPSCs) using microfluidic technologies and artificial intelligence (AI).

Key Points: 
  • The grant is aimed at the development of technologies enabling production of autologous induced pluripotent stem cells (iPSCs) using microfluidic technologies and artificial intelligence (AI).
  • The consortium members include MIDA Biotech B.V. (MIDA), DeepMed IO , and Leiden University , with MIDA acting as the leading entity.
  • The proprietary process is designed to standardize the GMP production of autologous iPSCs and speed production at a fraction of the current cost.
  • Current processes face numerous challenges, such as lack of reproducibility and high cost due to human involvement.

Emerging Markets Report: The Air We Share

Retrieved on: 
Tuesday, May 3, 2022
EMC, Communication, RISK, NOT, US, LLC, Company, Securities Act of 1933, SHARE, Time, PAID, RESEARCH, Closed-end fund, Advertising, Editorial, Marketing, Awareness, Risk, Security (finance)

ORLANDO, Fla., May 03, 2022 (GLOBE NEWSWIRE) -- Recent news from ATMOFIZER TECHNOLOGIES INC. (CSE: ATMO; OTCQB: ATMFF) is compelling for a number of reasons as we will outline herein. Atmofizer’s technology cleans the air we share in a revolutionary way using a patent-protected and patent pending technique which uses “agglomeration,” basically lumping all the bad stuff together so that it can be efficiently neutralized.

Key Points: 
  • This communication is a paid advertisement and is not a recommendation to buy or sell securities.
  • Emerging Markets Consulting, LLC, and their owners, managers, employees, and assigns (collectively EMC) has been paid by the profiled company or a third party to disseminate this communication.
  • This compensation is a major conflict with our ability to be unbiased, more specifically:
    This communication is for entertainment purposes only.
  • The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.

Camelot Event-Driven Fund Wins Lipper Award

Retrieved on: 
Thursday, April 21, 2022
Camelot, Mutual fund, Maritime Security Risk Analysis Model, LLC, Index, Fund, Transport, Risk management, Chart, Liquidity risk, Prospectus, California Managed Risk Medical Insurance Board, Interest rate risk, Investment, RISK, FINRA, Risk, Operational risk, Capital structure, Life insurance, Insurance, Financial adviser

Standard and Poors chooses member companies for the index based on market size, liquidity and industry group representation.

Key Points: 
  • Standard and Poors chooses member companies for the index based on market size, liquidity and industry group representation.
  • Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund.
  • This and other important information about the fund is contained in the prospectus, which can be obtained by calling 1-800-869-1679.
  • The Camelot Event Driven Fund is Distributed by Arbor Court Capital, LLC member FINRA / SIPC .

CBAT - 2021 Marked A Year of Turnaround, Backed By Strong Market Demands, Increasing Production Capacity & Integrated Supply of Lithium-Battery Materials

Retrieved on: 
Thursday, April 21, 2022
Lithium, EVS, Technology, GAAP, EV, CBAT, CBAK, Quality control, Research, Toyota, LEV, Traction, Broker-dealer, Regulation, Daihatsu, Risk, Yoy, Growth, The Company, AC, Company, Research report, Ecosystem, Environment, SEC, NOT, Stone Street, Investment, Lev Binzumovich Leviev, Income, RISK, Industry, Acquisition, Exercise, Stone Street (Manhattan), Security (finance)

Having stable raw materials supply is especially crucial in an environment of rising commodity prices.

Key Points: 
  • Having stable raw materials supply is especially crucial in an environment of rising commodity prices.
  • According to the Company, CBAT's Dalian lithium battery manufacturing plant is producing the model 26650/26700 battery at full capacity.
  • As of March, CBAT had ~ $36 million outstanding battery orders from its Dalian facility and 90% end users were overseas.
  • Considering the rising prices and the fact that the market is getting hotter, CBAT's material business is expected to grow quickly.

Magna’s Upcoming Investor Event to Include Update on Strategy and Feature Driving Experiences

Retrieved on: 
Tuesday, April 19, 2022
MGA, Engineering, AS, NYSE, TSX, RISK, THE, AND

We are a mobility technology company with a global, entrepreneurial-minded team of 158,000 employees and an organizational structure designed to innovate like a startup.

Key Points: 
  • We are a mobility technology company with a global, entrepreneurial-minded team of 158,000 employees and an organizational structure designed to innovate like a startup.
  • Our global network includes 343 manufacturing operations and 91 product development, engineering and sales centres spanning 28 countries.
  • For further information about Magna [(NYSE:MGA; TSX:MG)], please visit www.magna.com or follow us on Twitter @MagnaInt.
  • THESE DOCUMENTS ARE AVAILABLE FOR REVIEW ON MAGNAS WEBSITE AT WWW.MAGNA.COM.

Emerging Markets Report: The Mother of Invention

Retrieved on: 
Wednesday, April 6, 2022
Company, Risk, Advertising, Marketing, Editorial, Closed-end fund, EMC, Communication, LLC, RISK, Securities Act of 1933, Time, RESEARCH, US, NOT, Awareness, PAID, SHARE, Security (finance)

ORLANDO, Fla., April 06, 2022 (GLOBE NEWSWIRE) -- We are pleased today to introduce a new featured company, and one with its own proprietary technology in which the United States Patent Office issued a patent related to the Company’s air and water purification system that provides consumer and industrial solutions for the times we live in and beyond. Seismic events, like the COVID-19 outbreak, are often massive changes agents. Long after the cases and hospitalizations abate, a new desire for the world to be cleaner and safer will likely prevail.

Key Points: 
  • cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration.
  • This communication is a paid advertisement and is not a recommendation to buy or sell securities.
  • Emerging Markets Consulting, LLC, and their owners, managers, employees, and assigns (collectively EMC) has been paid by the profiled company or a third party to disseminate this communication.
  • This compensation is a major conflict with our ability to be unbiased, more specifically:
    This communication is for entertainment purposes only.

Labcorp Initiates Quarterly Dividend

Retrieved on: 
Thursday, April 7, 2022
Women, Other Health, Seniors, Pharmaceutical, Men, Oncology, Family, Medical Devices, Infectious Diseases, Hospitals, Consumer, Genetics, Clinical Trials, Cardiology, Biotechnology, Diabetes, AIDS, Health, Company, Drug development, LinkedIn, Form 10-Q, Board, NYSE, Public opinion, LH, SEC, Hospital, Health, Failure, Board of directors, Review, Intention, RISK, COVID-19, Information technology, Annual report, Patient, Local government, Holding company, Pharmaceutical industry, LabCorp

Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock.

Key Points: 
  • Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock.
  • The dividend will be payable on June 9, 2022, to stockholders of record as of the close of business on May 19, 2022.
  • The declaration and payment of the dividend is consistent with Labcorps previously announced intention to initiate paying quarterly dividends beginning in the second quarter of 2022.
  • Labcorp currently expects to continue to pay quarterly cash dividends, with future declarations subject to Board approval at its discretion.